Patents/Assignees

I2O THERAPEUTICS, Inc.

9 patents in portfolio

US12540168utility2026
Human Amylin Analog Polypeptides and Methods of Use
0 cites
US12350320utility2025
Compositions Comprising Pharmaceutically Acceptable Salts of Glucagon-like Peptide-1 Analogs and Pharmaceutically Acceptable Salts of Amylin Analogs, and Uses Thereof
0 cites
US12337029utility2025
Compositions Comprising Pharmaceutically Acceptable Salts of Amylin Analogs and Uses Thereof
0 cites
US12233111utility2025
Compositions Comprising Pharmaceutically Acceptable Salts of Glucagon-like Peptide-1 Analogs and Uses Thereof
0 cites
US12122816utility2024
Long Acting Peptide Tyrosine Tyrosine (PYY) Analogs and Methods of Use
0 cites
US12084485utility2024
Long Acting Glucagon Like Polypeptide-1 (GLP-1) Receptor Agonists and Methods of Use
0 cites
US12042557utility2024
Rapid Establishment And/or Termination of Substantial Steady-state Drug Delivery
0 cites
US12018059utility2024
Human Amylin Analog Polypeptides and Methods of Use
0 cites
US11840559utility2023
Glucagon-receptor Selective Polypeptides and Methods of Use Thereof
0 cites